ARTICLE | Clinical News
Kovaltry regulatory update
July 13, 2015 7:00 AM UTC
Bayer’s Bayer Yakuhin Ltd. subsidiary submitted an application in Japan for BAY 81-8973 to treat hemophilia A. The submission included data from the Phase III LEOPOLD I, LEOPOLD II and LEOPOLD Kids tr...